Search Results 801-810 of 17050 for pharmacogenetics

1. A Study to Evaluate the Use of AR-42 (Histone Deacetylase Inhibitor) in the Treatment of Vestibular Schwannoma and Meningioma - Mayo Clinic

   AR-42 is a small molecule which crosses the blood brain barrier (BBB) in rodents, but the investigators are not certain yet if it will penetrate human ...

2. Hematology - Clinical trials

   Hematology — Learn about innovative diagnosis and treatment options for blood diseases, including cancers, at Mayo Clinic.

3. Pilot Clinical Trial Evaluating the Utility of Minocycline as an Agent to Decrease Chemotherapy-Induced Peripheral Neuropathy (CIPN) and Paclitaxel-Induced Acute Pain Syndrome (P-APS): A Randomized Placebo-Controlled, Double Blind Trial - Mayo Clinic

   Pilot Clinical Trial Evaluating the Utility of Minocycline as an Agent to Decrease Chemotherapy-Induced Peripheral Neuropathy (CIPN) and Paclitaxel-Induced ...

4. Trial of IW-9179 in Patients With Diabetic Gastroparesis (DGP) - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

5. Effectiveness and Satisfaction With Brief Synchronous Tele-psychiatry Consult - Mayo Clinic

   This study is being conducted to assess the effectiveness and satisfaction of getting mental health consults using remote video consults through an iPad.

6. Multiple Myeloma Patient Registry - Clinical Trials

   About this study. The purpose of this study is to document the participants characteristics, disease burden, and clinical management of participants in the ...

7. Medical Research & Education - Mayo Clinic News Network

   ROCHESTER, Minn. — Mayo Clinic researchers have uncovered how aging "zombie cells" trigger harmful inflammation that accelerates a severe and increasingly ...

8. Veliparib and Topotecan Hydrochloride in Treating Patients With Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer - Mayo Clinic

   The purpose of this study is to determine the maximum tolerated dose of the combination of ABT-888 and weekly topotecan in adult patients with advanced solid ...

9. Medical Research & Education - Mayo Clinic News Network

   Mayo Clinic Researchers Identify Potential Immunotherapy Drug Combination for Targeting Advanced and Metastatic Cancers. Julie Janovsky-Mason. July 12, 2016.

10. Study of Lenzilumab and Axicabtagene Ciloleucel in Subjects with Relapsed or Refractory Large B-cell Lymphoma - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...